Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFT vs CMF in high-risk node-negative breast cancer
NCT00152191Phase 3Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Oct 1996
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur + uracil in breast cancer, sponsored by Taiho Pharmaceutical Co., Ltd.. Started Oct 1996; status: completed.
02
Drugs
tegafur + uracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00152191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152191.